Brought to you by 
MGI Pharma to buy Guilford Pharmaceuticals for $174mm
06 Sep 2005
Executive Summary
MGI Pharma has agreed to acquire all of Guilford Pharmaceuticals' 46.5mm outstanding shares for stock and cash totaling about $174mm. It will pay $3.75 per share (a 62% premium), comprising a fractional share of MGI stock worth $2.625--the exact fraction to depend on MGI's trading price just before the deal closes--plus $1.13 in cash.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Contract
- Intra-Biotech Deal
- Payment Includes Cash
- Payment Includes Stock
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
MGI Pharma to buy Guilford Pharmaceuticals for $174mm
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice